USPH stock holds above $80 as investors weigh earnings and dividend profile

USPH stock trades in the low $80s as of late August 2026, with investors balancing recent earnings trends, dividend yield and consensus expectations for the current fiscal year.

U.S. Physical Therapy, Inc. (USPH, ISIN US9175021020) stock has been trading in the low $80s in recent sessions as of late August 2026, reflecting a period in which investors are weighing the company’s latest earnings trends, dividend profile and consensus expectations for the current fiscal year.

Earnings momentum and recent quarterly figures

Recent compiled data for U.S. Physical Therapy show that the shares opened at $78.61 on a recent trading day, providing a reference level for assessing the stock’s performance against fundamental results in the most recent reporting period. According to an earnings overview for one of the latest quarters, the company reported earnings per share (EPS) of $0.75 for the period, measured against a consensus estimate of $0.81, indicating that EPS came in $0.06 below expectations for that quarter. The same quarterly snapshot indicated revenue of $214.06 million, set against analyst estimates of $211.36 million, meaning revenue exceeded expectations by $2.70 million even as EPS modestly trailed forecasts. In addition, the business was reported to have achieved a net margin of 3.97 percent and a return on equity of 9.39 percent in that period, underscoring that the company continues to convert its revenue base into positive bottom-line results despite the slight earnings miss.

The revenue performance in that quarter was also characterized by year-on-year growth, with revenue up 8.5 percent compared with the same period in the previous year, highlighting a solid expansion in the top line. During the same prior-year quarter, U.S. Physical Therapy was reported to have earned EPS of $0.81, which in the comparison with the more recent $0.75 figure shows a decline of $0.06 per share even as revenue advanced. This combination of higher revenue and slightly lower earnings per share suggests that cost dynamics, reimbursement mix or investment spending have been placing some pressure on margins, a factor that investors may be monitoring as they evaluate the company’s future profitability.

Dividend and consensus expectations

In addition to earnings and revenue trends, U.S. Physical Therapy’s dividend policy plays an important role in the stock’s appeal for income-oriented investors. Recent dividend information indicates that the company declared a quarterly dividend of $0.46 per share, with a record date set in late August and payment scheduled for mid-September 2026. On an annualized basis, this translates into a dividend of $1.84 per share. When measured against a share price in the high $70s to low $80s range, that annualized payout corresponds to a dividend yield in the low single digits, offering a modest but tangible cash return to shareholders.

The company’s dividend payout ratio, calculated on one recent metric set, was reported at a very high level when comparing the cash distribution to earnings under that specific methodology. While that ratio reflects the relationship between the dividend and a particular earnings measure, investors typically consider the sustainability of the payout by looking at forward earnings expectations and cash flow generation rather than solely relying on a historical payout ratio figure. Consensus data compiled for U.S. Physical Therapy indicate that sell-side analysts expect the company to generate EPS of 2.95 for the current fiscal year. When that forecast is paired with the annualized dividend of $1.84, it implies that the dividend represents a significant but potentially manageable portion of expected full-year earnings, provided that operating performance and cash flows remain stable.

Market valuation and price context

On the valuation side, the relationship between the current share price and the consensus target offers another context point for investors. One recent quantitative report shows U.S. Physical Therapy trading around $79.17, with a stated price target of $81.00 for the stock. This suggests that the shares are valued close to the implied target range from that specific framework, signaling that the market view embedded in that report sees limited upside from the prevailing price level under its assumptions. When the opening quote of $78.61 is considered alongside a recent quote in the low $80s range and the $81.00 target, the stock appears to trade within a relatively narrow band around the modeled fair value.

Another recent snapshot of compiled market data lists U.S. Physical Therapy with a share price of 80.05 and a daily percentage change of 4.70 percent in one trading window, indicating that the stock can exhibit meaningful short-term volatility even within an otherwise moderate price range. For investors, a move from roughly $78.61 to $80.05 represents a gain of $1.44 per share, which equates to a percentage increase just under 2 percent, underscoring how incremental shifts in sentiment or news flow can translate into noticeable price changes on individual sessions. While a detailed 52-week range and market capitalization figure were not included in the most recent visible data excerpt, the combination of a price in the high $70s to low $80s zone and an ongoing dividend stream frames the stock as a mid-cap healthcare services name with both growth and income characteristics.

Business model and role in outpatient therapy

U.S. Physical Therapy operates in the outpatient physical and occupational therapy segment, providing rehabilitative services to patients across a network of clinics in the United States. Its business model typically centers on partnerships with therapists and local operators, with revenue generated through patient visits, payer reimbursements and contractual arrangements with healthcare networks or employers. In practice, this means that the company’s performance is closely tied to patient volumes, reimbursement rates from commercial insurers, Medicare and other payers, and the efficiency with which its clinics manage staffing and occupancy costs.

Representative offerings from U.S. Physical Therapy include individualized treatment plans for orthopedic conditions, sports-related injuries and post-surgical rehabilitation. Patients may visit a clinic several times per week for a prescribed course of therapy, and the company earns revenue from each session. As the broader healthcare landscape continues to emphasize cost-effective, non-hospital settings for many treatments, outpatient physical therapy providers such as U.S. Physical Therapy can benefit from long-term tailwinds in demand. At the same time, the company must navigate reimbursement pressures, competition from hospital-affiliated therapy centers and continuously manage clinical quality and patient satisfaction to maintain its referral streams.

Shares trade steadily into late August 2026

As of late August 2026, U.S. Physical Therapy shares trading in the low $80s reflect a balance between the company’s documented revenue growth, its modest earnings miss in a recent quarter, the ongoing dividend payout and consensus expectations for the current fiscal year. For investors, the key numerical markers include quarterly revenue of $214.06 million against estimates of $211.36 million, EPS of $0.75 versus a prior-year $0.81 and a current-year EPS forecast of 2.95 paired with an annualized dividend of $1.84. Together, these figures suggest that while margins have seen some pressure, the business retains both growth and income attributes, and the stock price near the $80 mark aligns closely with at least one modeled target of $81.00.